Daisy Y. Shu

24 papers receiving 881 citations

Hit Papers

Myofibroblast transdifferentiation: The dark force in ocu...2017202620202023201750100150200250

Peers

Daisy Y. Shu
Comparison fields: 5 of 88
  • Molecular Biology 440
  • Ophthalmology 389
  • Radiology, Nuclear Medicine and Imaging 269
  • Cancer Research 95
  • Public Health, Environmental and Occupational Health 76
Replace Yan-Nian Hui with:
Yan-Nian Hui China
Tsung‐Chuan Ho Taiwan
Tine Van Bergen Belgium
Yukio Sassa Japan
S.-H. Park South Korea
Muneki Miura Japan
Hiroto Obata Japan
Lijie Dong China
Felicitas Bucher Germany
S. Kawahara Japan
Daisy Y. Shu relative to Yan-Nian Hui China Yan-Nian Hui's profile →
Citations per field
00.5×4.4×
Yan-Nian Hui · 1×
Citations per year

Countries citing papers authored by Daisy Y. Shu

Since Specialization
Citations

This map shows the geographic impact of Daisy Y. Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisy Y. Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisy Y. Shu more than expected).

Fields of papers citing papers by Daisy Y. Shu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisy Y. Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisy Y. Shu. The network helps show where Daisy Y. Shu may publish in the future.

Co-authorship network of co-authors of Daisy Y. Shu

This figure shows the co-authorship network connecting the top 25 collaborators of Daisy Y. Shu. A scholar is included among the top collaborators of Daisy Y. Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daisy Y. Shu. Daisy Y. Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 1
5 63
6 12
7 11
8 33
9 37
10 11
11 187
12 29
13 37
14 25
15 26
16 6
17 34
18
Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosisbreakdown →
294
19 17
20 3

About Daisy Y. Shu

Daisy Y. Shu is a scholar working on Ophthalmology, Neurology and Equine, having authored 26 papers that have together received 892 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (8 papers), Connexins and lens biology (7 papers) and Corneal Surgery and Treatments (5 papers). The work is most often cited by research in Ophthalmology (389 citations), Radiology, Nuclear Medicine and Imaging (269 citations) and Molecular Biology (440 citations). Daisy Y. Shu has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Frank J. Lovicu, Magali Saint‐Geniez, Mariana Aparecida Brunini Rosales, Jared Iacovelli, Suman Chaudhary, David C. Thorn, Anton Lennikov, William P. Miller, Tina B. McKay and Kin‐Sang Cho. Their work appears in journals such as Scientific Reports, The FASEB Journal and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026